Susanna High's most recent trade in Dyne Therapeutics Inc was a trade of 4,636 Common Stock done at an average price of $34.4 . Disclosure was reported to the exchange on Sept. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.41 per share. | 18 Sep 2024 | 4,636 | 131,636 | - | 34.4 | 159,525 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.41 per share. | 18 Sep 2024 | 4,340 | 136,272 | - | 34.4 | 149,339 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 11 Sep 2024 | 2,722 | 140,612 | - | 31.9 | 86,805 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 11 Sep 2024 | 2,548 | 143,334 | - | 31.9 | 81,256 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 21 Jun 2024 | 29,787 | 178,579 | - | 5.5 | 165,020 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 29,787 | 70,699 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 21 Jun 2024 | 29,787 | 148,792 | - | 35.0 | 1,042,843 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 10,163 | 60,536 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.33 per share. | 21 Jun 2024 | 10,163 | 148,792 | - | 35.3 | 359,059 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.54 per share. | 21 Jun 2024 | 10,163 | 158,955 | - | 5.5 | 56,303 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 1,616 | 187,882 | - | 10.7 | 17,324 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 94,893 | 189,498 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 36,952 | 36,952 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 02 Nov 2023 | 9,939 | 94,605 | - | 7.4 | 73,549 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 2,672 | 104,544 | - | 9.4 | 25,144 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 1,635 | 107,216 | - | 10.4 | 17,020 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 13 Jun 2023 | 1,625 | 108,851 | - | 12.4 | 20,199 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 14 Mar 2023 | 1,559 | 110,476 | - | 13.3 | 20,781 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 69,000 | 69,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 44,000 | 112,786 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 751 | 112,035 | - | 10.9 | 8,163 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 2,629 | 68,786 | - | 13.7 | 36,017 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 786 | 71,415 | - | 14.0 | 11,043 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 36,219 | 36,219 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 802 | 72,201 | - | 5.0 | 3,970 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 765 | 73,003 | - | 8.7 | 6,678 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 60,472 | 60,472 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 40,315 | 73,768 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 23 Sep 2021 | 2,451 | 33,453 | - | 17.2 | 42,206 | Common Stock |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 111,405 | 111,405 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Susanna High | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 35,904 | 35,904 | - | 0 | Common Stock |